The Daily Endorphin
Four minutes. Everything Indian medicine did yesterday.
A 6am brief on medicine, regulation and pharma, written by a practising surgeon for doctors who don’t have time for the trade press. Read it before your list starts.
Six segments. Same order, every morning.
You learn the shape once, then you read by segment. Skip what isn’t yours and you are out in ninety seconds.
Vitals
The numbers that moved overnight, each one with its denominator attached.
The Lead
One story explained properly, including what it changes in your own practice.
Regulatory Desk
NMC, CDSCO and NPPA orders read in the original circular, not in the press release.
Pharma & Markets
Approvals, pricing orders and results, in rupees, with the money behind them named.
One Paper Worth Your Time
A single paper, its method, its limits, and whether it should change anything.
Medicolegal
Judgments and consumer-forum orders, anonymised, shared for learning.
This is the whole product, straight through.
Four minutes is about nine hundred words: one story explained properly, three regulatory lines read in the original circular, one paper with its method and its limits, and one advertisement that says so.
Nothing is padded to fill a segment. On a morning when medicine did nothing worth your time, the brief says so and ends early.
Read the full sample issueThe List
Verified physicians only. Every subscriber confirms they practise before the first send.
Orthopaedics / Internal medicine / Paediatrics / General surgery / Anaesthesia / Radiology / Obstetrics & gynaecology / Emergency medicine / Cardiology / Psychiatry / Pathology / Oncology / Dermatology / Family medicine
Reading in district hospitals, medical colleges, corporate chains and single-doctor clinics — mostly on a phone, mostly before the list starts.
Dr. Aditya Seth
Orthopaedic trauma and joint replacement surgeon · Karnal, Haryana
I read the trade press the way you do: in a stairwell, between cases, on a phone with one bar of signal. Most of it is a press release with a headline attached, and by the time it reaches me the part that would change a decision has been cut.
The Daily Endorphin is what I wanted instead. Every clinical claim links to its source. Every regulatory line is read in the original circular before it is summarised. Where the evidence is thin, the brief says the evidence is thin.
Advertising pays for it. Advertising is labelled every time, and no advertiser sees a word before you do. That is the whole arrangement.
Credentials and disclosures at endorphinmd.com →Issues appear here from the first send.
How the brief is written.
Three rules, fixed before the first issue. They are the reason to trust a one-person newsroom, so they are published where you can hold them against it.
Sourcing
Every clinical and regulatory claim links to the primary document — the gazette notification, the order, the paper. If the only source is a company statement, it is described as a company statement.
Corrections
Errors are corrected at the top of the next brief, named as corrections, with the original wording shown. Nothing is edited quietly after the send.
Advertising
Pharma advertising funds the brief. Ads carry a label, sit in one fixed slot, and never take the voice of the editorial. No advertiser sees an issue before subscribers do.
Tomorrow, 6am IST
Four minutes tomorrow morning, and every morning after.
Free. One email at 7am IST. One-click unsubscribe, no argument.
EndorphinMD
The Daily Endorphin is the morning email brief of EndorphinMD. The long-form archive lives at Endorphinmd.com. One editor, one standard, two properties.
EndorphinMD
Model Town, Karnal
Haryana 132001, India